Best Practices Guideline on the Use of Neurofilament
Consortium of Multiple Sclerosis Centers (CMSC) Best Practices Guideline on the Use of Neurofilament Biomarkers in MS Erratum: This document…
Categories
Latest Blog Posts
- New Novartis data in relapsing MS reinforce benefits of Kesimpta® for first-line and switch patients
- Insomnia and MS: Expert Approaches to Better Sleep
- Press Release: FDA Approves Ocrevus Zunovo™ as the First and Only Twice-a-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
- Multiple Sclerosis and Mental Health: 3 Common Challenges
- 7 Tips for Talking with Friends and Family About Your Chronic Illness
- Battling the Dark Clouds of Depression When Living with MS
- The Ultimate Guide to MS for the Newly Diagnosed
- Cell-based therapeutic strategies for multiple sclerosis
- What to Know About Neuropathic Pain (and How to Manage It)
- video presentation Defining the “Pathways to Cures Roadmap” with global collaboration
- video: AGING and Multiple Sclerosis
- Re-defined Pathways to Cures Roadmap
- Managing Fatigue in MS and Pain Management
- Tibial nerve stimulation may ease sexual dysfunction related to MS
- Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis
- Why BOTHER taking MS Medications?
- MS and Sleep: Managing Night Sweats, Insomnia, and More
- Advocating for MS Adult Day Care Treatment Programs
- Best Practices Guideline on the Use of Neurofilament
- Medical Cannabis (drug) and Multiple Sclerosis: What does Science Say?